Levofloxacin Population Pharmacokinetics and Creation of a Demographic Model for Prediction of Individual Drug Clearance in Patients with Serious Community-Acquired Infection

Ítems similars

• Safety and Pharmacokinetics of Multiple 750-Milligram Doses of Intravenous Levofloxacin in Healthy Volunteers
  per: Chow, Andrew T., et al.
  Publicat: (2001)
• A Population Pharmacokinetic Analysis of the Penetration of the Prostate by Levofloxacin
  per: Drusano, G. L., et al.
  Publicat: (2000)
• Pharmacokinetics and Safety of High-Dose and Extended-Interval Regimens of Levofloxacin in Human Immunodeficiency Virus-Infected Patients
  per: Piscitelli, Stephen C., et al.
  Publicat: (1999)
• Levofloxacin Penetration into Epithelial Lining Fluid as Determined by Population Pharmacokinetic Modeling and Monte Carlo Simulation
  per: Drusano, G. L., et al.
  Publicat: (2002)
• Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.
  per: Chien, S C, et al.
  Publicat: (1997)